Insmed (INSM)

Insmed Financial Statements


Insmed Financial Overview

Insmed's market cap is currently ―. The company's EPS TTM is $-3.511; its P/E ratio is -6.59; Insmed is scheduled to report earnings on November 3, 2022, and the estimated EPS forecast is $-0.88. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 65.22M$ 53.11M$ 56.12M$ 46.76M$ 45.37M
Gross Profit$ 48.83M$ 40.92M$ 42.84M$ 36.57M$ 34.53M
EBIT$ -92.61M$ -91.77M$ -102.21M$ -104.59M$ -106.84M
EBITDA$ -90.39M$ -89.22M$ -98.83M$ -101.09M$ -103.19M
Net Income Common Stockholders$ -95.64M$ -94.62M$ -112.98M$ -112.71M$ -117.32M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 409.75M$ 532.76M$ 554.87M$ 588.75M$ 635.12M
Total Assets$ 1.05B$ 1.15B$ 1.24B$ 1.31B$ 1.23B
Total Debt$ 394.58M$ 399.37M$ 407.21M$ 593.80M$ 603.81M
Net Debt$ -15.17M$ -133.39M$ -147.66M$ 5.05M$ -31.31M
Total Liabilities$ 1.01B$ 1.03B$ 833.04M$ 806.93M$ 698.73M
Stockholders Equity$ 44.24M$ 119.88M$ 201.64M$ 275.88M$ 357.06M
Cash Flow
Free Cash Flow$ -105.20M$ -106.86M$ -85.27M$ -76.93M$ -78.93M
Operating Cash Flow$ -102.30M$ -105.16M$ -84.13M$ -75.44M$ -75.44M
Investing Cash Flow$ -2.90M$ -101.41M$ -51.22M$ -8.40M$ -3.48M
Financing Cash Flow$ 6.31M$ 6.46M$ 5.71M$ 2.54M$ 597.60M
Currency in USD

Insmed Earnings and Revenue History

Insmed Debt to Assets

Insmed Cash Flow

Insmed Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis